+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Targeted Therapies"

From
From
SAB-176 Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

SAB-176 Emerging Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
Cancer Microbiome Market Report and Forecast 2025-2034 - Product Thumbnail Image

Cancer Microbiome Market Report and Forecast 2025-2034

  • Report
  • July 2025
  • 350 Pages
  • Global
From
From
Biologics CDMO Market Report and Forecast 2025-2034 - Product Thumbnail Image

Biologics CDMO Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Asia Pacific Biosimulation Market Report and Forecast 2024-2032 - Product Thumbnail Image

Asia Pacific Biosimulation Market Report and Forecast 2024-2032

  • Report
  • June 2024
  • 140 Pages
  • Asia Pacific
From
Peptide Therapeutics Market Report and Forecast 2023-2031 - Product Thumbnail Image

Peptide Therapeutics Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 147 Pages
  • Global
From
From
Biopharmaceuticals Market Report and Forecast 2023-2031 - Product Thumbnail Image

Biopharmaceuticals Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 140 Pages
  • Global
From
Bio-Pharma Market 2025-2029 - Product Thumbnail Image

Bio-Pharma Market 2025-2029

  • Report
  • June 2025
  • 229 Pages
  • Global
From
From
Exosomes- Pipeline Insight, 2025 - Product Thumbnail Image

Exosomes- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 280 Pages
  • Global
From
Allogenic Cell Therapies - Pipeline Insight, 2025 - Product Thumbnail Image

Allogenic Cell Therapies - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Allogenic INKT Cell Therapy - Pipeline Insight, 2025 - Product Thumbnail Image

Allogenic INKT Cell Therapy - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Targeted Therapies market within the context of Genomics is focused on the development of treatments that target specific genetic mutations or pathways. These therapies are designed to be more effective and have fewer side effects than traditional treatments. Genomics has enabled the development of personalized treatments that are tailored to the individual patient's genetic makeup. This has allowed for the development of drugs that target specific mutations or pathways, leading to more effective treatments. The Targeted Therapies market is a rapidly growing field, with many companies investing in research and development. Companies such as Gilead Sciences, Novartis, and AstraZeneca are leading the way in the development of targeted therapies. Other companies such as Merck, Pfizer, and Roche are also investing in the development of targeted therapies. Show Less Read more